Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:35 pm Sale | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 46,013,752 6.400% | -8,085,314 (-14.95%) | Filing History |
| 2025-05-15 4:35 pm Purchase | 2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | VIKING GLOBAL INVESTORS LP | 6,572,700 9.200% | 2,572,700 (+64.32%) | Filing History |
| 2025-05-15 4:34 pm Purchase | 2025-03-31 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 9,190,486 8.700% | 2,591,424 (+39.27%) | Filing History |
| 2025-05-15 4:34 pm Purchase | 2025-03-31 | 13G | Acuren Corporation TIC | VIKING GLOBAL INVESTORS LP | 34,360,000 28.300% | 34,360,000 (New Position) | Filing History |
| 2025-04-18 09:45 am Purchase | 2025-04-11 | 13G | Regal Rexnord Corporation RRX | VIKING GLOBAL INVESTORS LP | 3,546,112 5.300% | 3,546,112 (New Position) | Filing History |
| 2025-03-12 4:28 pm Unchanged | 2025-01-31 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 22,055,375 11.700% | 0 (Unchanged) | Filing History |
| 2025-03-12 4:27 pm Unchanged | 2024-02-01 | 13D | Cazoo Group Ltd CZOOF | VIKING GLOBAL INVESTORS LP | 2,142,728 43.800% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:58 pm Purchase | 2025-02-10 | 13G | Sionna Therapeutics, Inc. SION | VIKING GLOBAL INVESTORS LP | 2,952,754 6.700% | 2,952,754 (New Position) | Filing History |
| 2025-02-14 4:50 pm Sale | 2024-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | VIKING GLOBAL INVESTORS LP | 0 0.000% | -1,752,656 (Position Closed) | Filing History |
| 2025-02-14 4:50 pm Sale | 2024-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS | VIKING GLOBAL INVESTORS LP | 6,978,534 6.500% | -1,046,031 (-13.04%) | Filing History |
| 2025-02-14 4:50 pm Sale | 2024-12-31 | 13G | APi Group Corporation APG | VIKING GLOBAL INVESTORS LP | 32,306,277 7.800% | -8,242,497 (-20.33%) | Filing History |
| 2025-01-31 7:18 pm Sale | 2025-01-31 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 22,055,375 11.700% | -3,065,616 (-12.20%) | Filing History |
| 2024-11-14 4:32 pm Unchanged | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | VIKING GLOBAL INVESTORS LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 8.300% | 3,577,128 (New Position) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | VIKING GLOBAL INVESTORS LP | 1,481,146 1.600% | -4,678,000 (-75.95%) | Filing History |
| 2024-11-14 4:31 pm Unchanged | 2024-09-30 | 13G | PepGen Inc. PEPG | VIKING GLOBAL INVESTORS LP | 1,482,434 4.500% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | VIKING GLOBAL INVESTORS LP | 0 0.000% | -4,247,914 (Position Closed) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 54,099,066 7.300% | -15,269,895 (-22.01%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 721,926 0.600% | -4,423,186 (-85.97%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Verastem, Inc. VSTM | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,531,829 (Position Closed) | Filing History |